Micromedex 2.0
is trusted by more than 3,500 hospitals and in 80 countries because our drug information the highest quality available. The evidence-based information in Micromedex 2.0 is the result of comprehensive, ongoing review and recommendations from the world’s medical journals by our in-house editorial staff of more than 90 dedicated physicians, clinical pharmacists, nurses, and medical librarians.
We review, evaluate, and synthesize more than half a million articles annually to provide the best treatment recommendations and guidelines. Our meticulous process and highly trained editorial staff ensure that Micromedex 2.0 evidence is fully vetted and integrated into our products quickly so you can be confident that your decisions are based on the most current data available.
Check out this helpful video to learn more about Micromedex 2.0 content: Micromedex Editorial Process.
- Compendia Transparency
- Drug Interactions Data
- Off-Label Indication Policy
- Conflict of Interest Policy
- Evidence Process
Content Insights
Submitting Information:
RED BOOK Submissions
Off-Label Information
POISINDEX Information System


